Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: Imaging and local therapy

Joseph A. Sparano, Etta D. Pisano, Julia R. White, Kelly K. Hunt, Eleftherios P. Mamounas, Edith A. Perez, Gabriel N. Hortobagyi, Julie R. Gralow, Robert L. Comis

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Imaging and local therapy are important modalities for detection and management of localized breast cancer. Improvements in screening and local therapy have contributed to reduced breast cancer-associated morbidity and mortality. The Coalition of Cancer Cooperative Groups (CCCG) convened the Scientific Leadership Council (SLC) in breast cancer, an expert panel, to identify priorities for future research and current trials with greatest practice-changing potential. Panelists formed a consensus on research priorities for breast imaging and locoregional therapy, and also identified six trials judged to be of high priority. Current high priority trials included trials determining: (1) the role of accelerated partial breast versus whole-breast radiation (B39), (2) the feasibility, safety, and local and systemic control of small localized breast cancers treated with tumor ablation (Z 1072), (3) the role of removal of the primary cancer in selected patients with metastatic disease (E2108), and (4) the clinical and biological effects of pre-operative anti-HER2-directed and ER-directed therapies in localized or locally advanced breast cancer (B41, Z1031, Z1041). Ongoing and future trials will further refine optimal locoregional management, and additional research is required to develop improved screening methods and identify high risk populations most likely to benefit from targeted screening.

Original languageEnglish (US)
Pages (from-to)273-284
Number of pages12
JournalBreast Cancer Research and Treatment
Volume120
Issue number2
DOIs
StatePublished - Apr 2010

Fingerprint

Breast Neoplasms
Research
Breast
Neoplasms
Therapeutics
Consensus
Radiation
Morbidity
Safety
Mortality
Population

Keywords

  • Breast cancer
  • Imaging
  • Radiation therapy local therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council : Imaging and local therapy. / Sparano, Joseph A.; Pisano, Etta D.; White, Julia R.; Hunt, Kelly K.; Mamounas, Eleftherios P.; Perez, Edith A.; Hortobagyi, Gabriel N.; Gralow, Julie R.; Comis, Robert L.

In: Breast Cancer Research and Treatment, Vol. 120, No. 2, 04.2010, p. 273-284.

Research output: Contribution to journalArticle

Sparano, Joseph A. ; Pisano, Etta D. ; White, Julia R. ; Hunt, Kelly K. ; Mamounas, Eleftherios P. ; Perez, Edith A. ; Hortobagyi, Gabriel N. ; Gralow, Julie R. ; Comis, Robert L. / Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council : Imaging and local therapy. In: Breast Cancer Research and Treatment. 2010 ; Vol. 120, No. 2. pp. 273-284.
@article{845e60a42865432ba3af125533bd5e52,
title = "Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: Imaging and local therapy",
abstract = "Imaging and local therapy are important modalities for detection and management of localized breast cancer. Improvements in screening and local therapy have contributed to reduced breast cancer-associated morbidity and mortality. The Coalition of Cancer Cooperative Groups (CCCG) convened the Scientific Leadership Council (SLC) in breast cancer, an expert panel, to identify priorities for future research and current trials with greatest practice-changing potential. Panelists formed a consensus on research priorities for breast imaging and locoregional therapy, and also identified six trials judged to be of high priority. Current high priority trials included trials determining: (1) the role of accelerated partial breast versus whole-breast radiation (B39), (2) the feasibility, safety, and local and systemic control of small localized breast cancers treated with tumor ablation (Z 1072), (3) the role of removal of the primary cancer in selected patients with metastatic disease (E2108), and (4) the clinical and biological effects of pre-operative anti-HER2-directed and ER-directed therapies in localized or locally advanced breast cancer (B41, Z1031, Z1041). Ongoing and future trials will further refine optimal locoregional management, and additional research is required to develop improved screening methods and identify high risk populations most likely to benefit from targeted screening.",
keywords = "Breast cancer, Imaging, Radiation therapy local therapy",
author = "Sparano, {Joseph A.} and Pisano, {Etta D.} and White, {Julia R.} and Hunt, {Kelly K.} and Mamounas, {Eleftherios P.} and Perez, {Edith A.} and Hortobagyi, {Gabriel N.} and Gralow, {Julie R.} and Comis, {Robert L.}",
year = "2010",
month = "4",
doi = "10.1007/s10549-009-0655-z",
language = "English (US)",
volume = "120",
pages = "273--284",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council

T2 - Imaging and local therapy

AU - Sparano, Joseph A.

AU - Pisano, Etta D.

AU - White, Julia R.

AU - Hunt, Kelly K.

AU - Mamounas, Eleftherios P.

AU - Perez, Edith A.

AU - Hortobagyi, Gabriel N.

AU - Gralow, Julie R.

AU - Comis, Robert L.

PY - 2010/4

Y1 - 2010/4

N2 - Imaging and local therapy are important modalities for detection and management of localized breast cancer. Improvements in screening and local therapy have contributed to reduced breast cancer-associated morbidity and mortality. The Coalition of Cancer Cooperative Groups (CCCG) convened the Scientific Leadership Council (SLC) in breast cancer, an expert panel, to identify priorities for future research and current trials with greatest practice-changing potential. Panelists formed a consensus on research priorities for breast imaging and locoregional therapy, and also identified six trials judged to be of high priority. Current high priority trials included trials determining: (1) the role of accelerated partial breast versus whole-breast radiation (B39), (2) the feasibility, safety, and local and systemic control of small localized breast cancers treated with tumor ablation (Z 1072), (3) the role of removal of the primary cancer in selected patients with metastatic disease (E2108), and (4) the clinical and biological effects of pre-operative anti-HER2-directed and ER-directed therapies in localized or locally advanced breast cancer (B41, Z1031, Z1041). Ongoing and future trials will further refine optimal locoregional management, and additional research is required to develop improved screening methods and identify high risk populations most likely to benefit from targeted screening.

AB - Imaging and local therapy are important modalities for detection and management of localized breast cancer. Improvements in screening and local therapy have contributed to reduced breast cancer-associated morbidity and mortality. The Coalition of Cancer Cooperative Groups (CCCG) convened the Scientific Leadership Council (SLC) in breast cancer, an expert panel, to identify priorities for future research and current trials with greatest practice-changing potential. Panelists formed a consensus on research priorities for breast imaging and locoregional therapy, and also identified six trials judged to be of high priority. Current high priority trials included trials determining: (1) the role of accelerated partial breast versus whole-breast radiation (B39), (2) the feasibility, safety, and local and systemic control of small localized breast cancers treated with tumor ablation (Z 1072), (3) the role of removal of the primary cancer in selected patients with metastatic disease (E2108), and (4) the clinical and biological effects of pre-operative anti-HER2-directed and ER-directed therapies in localized or locally advanced breast cancer (B41, Z1031, Z1041). Ongoing and future trials will further refine optimal locoregional management, and additional research is required to develop improved screening methods and identify high risk populations most likely to benefit from targeted screening.

KW - Breast cancer

KW - Imaging

KW - Radiation therapy local therapy

UR - http://www.scopus.com/inward/record.url?scp=77950689917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950689917&partnerID=8YFLogxK

U2 - 10.1007/s10549-009-0655-z

DO - 10.1007/s10549-009-0655-z

M3 - Article

C2 - 20024613

AN - SCOPUS:77950689917

VL - 120

SP - 273

EP - 284

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -